YES Bank Q3 net profit rises 22%

YES Bank announces Financial Results for the Quarter and Nine Months ended December 31, 2017


Balance Sheet crossed INR 2.5 Lakh Crores and Advances crossed INR 1.5 Lakh Crores

Total Capital Funds at INR 43,596.3 Crores, increase of 62.3% y-o-y. Healthy Capital Adequacy with Total CRAR at 19.5%, Tier I at 14.7% and CET I at 10.7%

Robust growth of 46.5% in Advances, with increasing granularity. Retail Banking advances doubled in last one year to 11.8% of Total Advances. Combined with MSME has grown to 32.3% from 31.1% y-o-y

Asset Quality continues to be stable. Credit Cost at 18 bps for Q3FY18 and 64 bps for 9MFY18

1st company to establish MTN programme on Global Securities Market of India International Exchange at the GIFT City IFSC

Included into S&P BSE Sensex. Also, included in MSCI ESG Global Indices based on strong performance on Environmental, Social & Governance parameters

PROFIT & LOSS (P&L): Operating and Net Profitability – Sustained Delivery

Net Profit of INR 1,076.9 Crores in Q3FY18; y-o-y growth of 22.0%

Net Interest Income of INR 1,888.8 Crores for Q3FY18; y-o-y growth of 26.8%

Non-Interest Income of INR 1,422.3 Crores for Q3FY18; y-o-y growth of 39.9%

Total Net Income of INR 3,311.1 Crores in Q3FY18 y-o-y growth of 32.1%

Operating Profit of INR 2,001.8 Crores for Q3FY18; y-o-y growth of 37.7%

NIMs healthy at 3.5% for Q3FY18. Cost to Income Ratio at 39.5%

Satisfactory return ratios with RoA at 1.7% and RoE at 18.0%. Book Value at INR 106.8 per share

The Total Assets grew by 36.2% y-o-y to INR 2,65,432.0 Crores, crosses significant growth milestone of INR 2.5 Lakh Crores

CASA ratio at 38.0%, an increase of 4.7% in one year, on the back of 48.0% y-o-y growth.

Yash Ved
Yash Ved is a Senior Correspondent at NewsBarons and comes with a decade of experience across leading online and offline publications. A keen observer of the stock index movement, Yash also likes covering Real Estate and the BFSI sector. A financial management and Journalism student, Yash believes learning as a continuous journey and enjoys following the IT and the Pharmaceutical industry and has penned many articles on the subjects.